Stay updated on Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Sign up to get notified when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    New navigation/help sections and metadata labels were added, including Last verified, Last known status was:, How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment, and a Revision: v3.6.0 line. The previous labels and formatting (e.g., Intervention / Treatment and Revision: v3.5.5) were replaced or removed.
    Difference
    1%
    Check dated 2026-06-12T12:37:53.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Results Submitted is now shown on the study record, and the page revision is updated to v3.5.5. This reflects that results have been submitted and the record has a newer version.
    Difference
    0.1%
    Check dated 2026-06-05T08:33:21.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Version tag updated from v3.5.3 to v3.5.4, indicating a new release of the page. It represents an update to the page's metadata rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-05-14T23:11:00.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.5.3 is now displayed, replacing Revision: v3.5.2 on the page. This indicates a software update to the underlying component, with no changes to study content.
    Difference
    0.1%
    Check dated 2026-04-30T18:43:52.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Added a new revision tag 'Revision: v3.5.2' and removed the older tag 'Revision: v3.5.0'.
    Difference
    0.1%
    Check dated 2026-04-16T10:49:47.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a new publication to the Publications section: Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis. Lancet Oncol. 2024 Nov;25(11):1465-1475.
    Difference
    0.1%
    Check dated 2026-04-02T01:37:43.000Z thumbnail image

Stay in the know with updates to Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.